A monthly read on announced Australian takeovers and schemes: what is live, what is moving, and the themes shaping control transactions.
Nine patterns stood out across the deals announced since 1 April, from a mining-led consolidation wave and two-tier bid pricing to contested control, consortiums that team up to break up their targets, and companies re-domiciling to the US for defence and critical-minerals funding.
Two-thirds of the book. Eight of the twelve announced deals are in Metals & Mining, split across gold (three), copper (three) and lithium (two). Record gold prices and the scramble for critical-minerals supply are driving a wave of consolidation among ASX-listed miners and developers.
Four of the twelve deals are all-scrip, every one in Metals & Mining, and a fifth, Vault, is cash-and-scrip. Outside mining, cash rules (seven of twelve overall). Miners are using paper to combine and build scale while preserving cash for development.
By far the largest deal, and now won. IFM's Diamond Infraco vehicle pursued toll-road owner Atlas Arteria in a A$7.4bn off-market bid at A$5.10 per security, stated to be best and final. The board urged rejection as too low and the contest produced two Takeovers Panel applications, but after four years of pursuit IFM took control: the offer closed on 7 July with the bidder holding 67.43% of the register.
Bidders are front-loading best-and-final language to anchor price and discourage a drawn-out contest. Advanced Innergy took that stance from the outset in its A$0.40 cash scheme for Matrix Composites, and IFM used it to cap its Atlas Arteria offer at A$5.10. The tactic reaches beyond this quarter's book too: the consortium of SGH (formerly Seven Group Holdings) and Steel Dynamics pitched its roughly A$15bn cash bid for BlueScope Steel as best and final absent a superior proposal. Used early, the statement signals discipline and puts the onus on the target. In most cases it is expressed to be subject to no competing superior proposal emerging, so it constrains a bidder against sweetening in the absence of a rival rather than narrowing its room to respond if one emerges.
With markets rattled by the 2026 conflict involving Iran, the closure of the Strait of Hormuz and the resulting oil and inflation shock, bidders are increasingly reserving the right to walk if the market falls materially before completion. Two deals in this quarter's book show it across structures: Advanced Innergy's scheme for Matrix Composites carries an S&P/ASX 200 trigger, while IFM's off-market bid for Atlas Arteria included a no-market-fall condition among its defeating conditions. These clauses push some of the macro risk back onto targets between signing and close, and targets are pushing back on where the trigger is set.
Control is being fought over again, in gold and in copper. Vault Minerals agreed an all-scrip merger with Regis Resources (5 May), then Genesis Minerals tabled a superior A$5.6bn proposal (a 14.5% premium) that the Vault board declared superior; Regis declined to match on 13 July, leaving Genesis to proceed. Separately, shortly after Genesis Minerals emerged, Austral Resources lodged a competing scheme for Hammer Metals at a 29.9% premium to the agreed Larvotto deal. Two live contests in one quarter is a shift after a quiet stretch.
Atlas Arteria put a structuring technique in the spotlight: a two-tier bid price. From the outset IFM offered A$4.75 per security, set to step up to A$5.10 if its relevant interest reached 45% before the offer closed, a design that rewards momentum and nudges holders to accept early, with everyone receiving the higher price if the threshold is met. It is not without complexity. The Takeovers Panel flagged that the 45% threshold could be crossed too late on the last day to lodge a price-variation notice under section 650D; IFM obtained ASIC relief to modify the mechanism, and gave an undertaking on late acceptances, before the Panel was satisfied and declined to intervene. The structure is not new: Fortescue used a cleaner version in its 2025 takeover of Red Hawk Mining, lifting the price from A$1.05 to A$1.20 if it reached 75% within seven days of the offer opening, a fixed early window that avoided the end-of-offer timing issue. Two examples are not yet a trend, but two-tier pricing is a device worth watching.
Another structuring device is the consortium that acquires a whole company in order to split it. Each member wants only a part, but together they can bid for all of it, share the funding, and put a single offer in front of the target's board. Steadfast is the clean local example: on completion the Amwins and Dragoneer consortium would divide the group, with the retail broking network going to one and the underwriting agencies to the other.
The BlueScope Steel approach is the same idea at scale. SGH and Steel Dynamics proposed to acquire all of BlueScope by scheme, with SGH to keep the Australian and rest-of-world businesses and on-sell the North American operations, the North Star steel mill and the building and coated products businesses, to Steel Dynamics. BlueScope has rejected the approaches as undervaluing the company, and its board pressed the consortium on how value was attributed to each half. That is what makes these deals demanding to assess. A single headline price and one shareholder vote can, in substance, be three transactions in one: the acquisition of the listed company, and the onward sale of each business segment as if it were being sold separately under private treaty. The target board, and its independent expert, has to test whether every piece stands up on its own valuation, not just whether the top-line number looks adequate, because each consortium member gains if its segment is priced cheaply inside the bundle. Add the competition review of the onward sale, its bearing on execution and timing, and the disclosure to shareholders about who ends up with what, and a clean-looking offer is a good deal more layered than it first appears.
A different use of the scheme emerged this quarter, driven by Washington rather than a bidder. Nova Minerals used a scheme to shift its parent to the United States, re-listing on the NYSE American to sit alongside its Alaskan antimony and gold project and a US$43.4 million Pentagon award to build a domestic antimony supply chain. Amaero, a Tennessee-based maker of titanium and refractory alloy powders, did the same: re-domiciling to Delaware with Federal Court approval, expressly to clear the foreign-ownership hurdles that block access to classified US defence work and to reach deeper American capital pools.
Neither transaction involved a change of control. They are top-hat restructures (a new parent inserted above the existing group), and they fall outside the deal board strictly defined. But they belong here because the forces driving them are the same forces now reshaping M&A timetables.
Case in point: Energy Fuels' scheme to acquire rare-earths producer Australian Strategic Materials had its securityholder meeting pushed from June to August at short notice. Energy Fuels secured a conditional US$725 million financing commitment from the Office of Strategic Capital (the Pentagon's investment arm) and separately agreed to acquire Germany's Vacuumschmelze. Both developments required fresh disclosure to ASM holders, and the vote could not proceed until they had absorbed it.
The pattern is clear. If a company's asset base touches antimony, rare earths, titanium, or uranium, assume Washington has a view on where the holding company should sit and how quickly the deal can close.
The whole quarter on one canvas, now extendable to the last six months. Every bubble is a deal, placed by announcement date and sized by value; hover for the detail, click to jump to it in the table. Recolour or filter the view and the chart and table move together.
Filter by structure, consideration, sector or timeframe, search by name, or sort any column. Filters apply to the chart above too.
| Target ▲▼ | Bidder ▲▼ | Announced ▲▼ | Structure ▲▼ | Sector ▲▼ | Value ▲▼ | Consideration ▲▼ |
|---|
All twelve transactions were on foot during the period; the Atlas Arteria offer has since closed, with IFM taking control at 67.43%. Values are as recorded at announcement unless marked. † Vault reflects the superior Genesis proposal (A$5.6bn); the original Regis scheme implied about A$4.6bn. ‡ Hammer is contested: the value shown reflects Austral Resources' competing proposal of 7 July 2026 (A$0.087 per share, about A$80.7m, a 29.9% premium to the Larvotto terms, though Larvotto notes the Austral exchange ratio is not yet fixed); the Hammer board continues to recommend the Larvotto scheme (about A$54m) absent a superior proposal. European Lithium is denominated in US dollars.
IFM has won. After four years of stalking Atlas Arteria, the infrastructure fund closed its hostile bid on 7 July with 67.43%, enough to control the board and redirect strategy.
The offer started at A$4.75 per security, stepping up to A$5.10 once IFM crossed 45%, which it did in mid-June. IFM called it best and final. The independent directors called it inadequate. Neither side blinked, and the Panel, asked twice, declined to intervene on either the bid structure or IFM's complaints about Chicago Skyway disclosure.
Control brings IFM straight into a fight it picked from the outside. To neutralise a change-of-control poison pill at the Chicago Skyway, one that would have let Ontario Teachers' Pension Plan exit its one-third stake at a premium, Atlas agreed to pay Ontario Teachers roughly US$100 million. IFM called that a waste of money when it had no vote. Now it has the vote, and a "full strategic review" is underway.
Debbie Goodin is out as chair, effective immediately on close. John Wigglesworth holds the seat on an interim basis.
Vault's agreed merger with Regis Resources lasted exactly two months before Genesis Minerals gatecrashed it. Genesis lodged an unsolicited proposal in early July offering 0.7629 shares plus A$0.475 cash per Vault share, implying A$5.274 and a 14.5% premium to the Regis terms. Vault's board has unanimously called it superior. On 13 July, Regis confirmed it would not match.
The Genesis offer implies roughly A$5.27 per Vault share (0.7629 Genesis shares plus A$0.475 cash), against A$4.61 implied under the Regis scheme (0.6947 Regis shares, all scrip). That is a 14.5% premium, and it comes with cash, which in a gold equity market trading on sentiment, not just NAV, matters.
Regis could have matched if it wanted to. Debt-free and holding about A$1.2 billion in cash and bullion, it would have topped up the cash component rather than issue more scrip, noting as well that under the previously agreed ratio, former Vault holders would already own about 49% of the merged group, so sweetening with more scrip risked tipping their stake past 50%, turning a "merger of equals" into a reverse takeover and triggering a Regis shareholder vote. It chose not to, concluding that matching the Genesis terms would not clear the value and return thresholds it applies to growth. Vault has since terminated the Regis SID, paying a break fee of about A$50.7 million, and on 14 July entered a binding SID with Genesis, unanimously recommended by the Vault board. The merged group would rank among Australia's top three gold producers, worth about A$12.6 billion, with Vault shareholders holding about 40.2% and completion targeted for late 2026.
Hammer's agreed scheme with Larvotto Resources has drawn a competing bid, but the contest is asymmetric: one deal is signed, the other is a statement of intent. Larvotto struck a board-recommended, all-scrip scheme on 11 June: one Larvotto share for every 22 Hammer shares, valuing Hammer at roughly A$54 million, with the WA gold assets spun into an unlisted vehicle.
Four weeks later, Austral Resources lodged a non-binding indicative proposal at an implied A$0.087 per Hammer share (approximately A$80.7 million), a 29.9% headline premium to the Larvotto terms. The consideration is also all scrip: A$0.080 in new Austral shares plus A$0.007 of implied value in the same gold demerger. It is backed by voting-intention statements covering 6 to 7% of Hammer's register.
The Hammer board has assessed Austral's proposal as a bona fide competing proposal that could reasonably become superior, the formulation that cracks open the fiduciary exception in the Larvotto SID and lets Hammer engage, share diligence, and negotiate without breaching its exclusivity undertakings. For now, the board unanimously continues to recommend the Larvotto scheme.
The deeper question for Hammer shareholders is what they are buying into. Larvotto is a A$662 million company with daily trading liquidity of A$3 million and a gold-antimony project nearing production. Austral is a A$175 million company with a processing plant targeting recommissioning in mid-2027 and A$75 million in cash. Austral's thesis is industrial consolidation across the Mt Isa copper belt, with Hammer's Kalman deposit as long-term Rocklands feed. Larvotto's thesis is near-term cash flow from Hillgrove and critical-minerals exposure. Both are all-scrip; neither offers Hammer shareholders a liquidity event. The question is not just headline premium but what the scrip is worth in twelve months.
Austral's next move is to convert its letter into a binding proposal with a fixed ratio. If it can do that, the matching right triggers and Larvotto has five days to respond. If it cannot, it remains Advantage Larvotto.
As this edition went to press, the Takeovers Panel revised the guidance it applies to remedies it may order when it determines to conduct proceedings to resolve takeover disputes. On 8 July 2026 it published a new version of Guidance Note 4 on Remedies General (GN 4), the seventh issue (release TP26/042) of Guidance Note 4, following a December 2025 consultation paper. GN 4 sets out the Panel's approach to remedies once a matter is before it: interim orders, declarations of unacceptable circumstances, final orders including costs, and undertakings.
The revised note adds a statement of purpose near the start that it did not carry before: the guidance provides a reminder to market participants that the Panel's role is to ensure applications are resolved as quickly and efficiently as possible, and to help minimise conduct by parties or their advisers that impedes proceedings. The examples the Panel gives are pointed, being a failure to answer questions directly and a failure to produce documents or other materials when first asked. The signal to market participants, and their advisers, is clear: a party's conduct during Panel proceedings, not only the merits of the party's position, is a relevant factor for the Panel when it considers how to exercise its powers to remedy the circumstances.
The previous description of costs orders as "the exception not the rule" has been removed; the note now simply states that costs do not follow a successful party as a matter of course. This may leave the door open for the Panel to take a more liberal approach to awarding costs in order to deter misconduct. The list of conduct that can attract a costs order has been expanded to capture, among other things, unnecessarily elongating proceedings by not answering questions or producing documents, submitting materially inaccurate material, unreasonably delaying becoming a party, and ignoring a reasonable request to fix clearly unacceptable circumstances before an application is even lodged. The Panel adds that, in appropriate cases, a costs order may substantively cover a party's entire legal costs. A new footnote reminds parties to check the accuracy of material they file, particularly where it is generated by artificial intelligence. Further, the Panel will generally not award a costs order in favour of an unrepresented party in relation to their own time spent in the proceedings, however in its recent decision in Mobile Asset Holdings Ltd [2026] ATP 7, the Panel confirmed that costs of external legal advisers may be recoverable by an unrepresented party.
On quantum the revised note is more explicit. The Panel may have regard to the Federal Court scale of fees on a party-and-party basis, being costs fairly and reasonably incurred, and where warranted may award costs on an indemnity basis. It confirms that a costs order may be made not only against a party, but against that party's directors or their legal advisers, and that costs orders may extend to the cost of recovering costs.
The note emphasises that the Panel welcomes any offer, such as undertakings, by a party to remedy potential unacceptable circumstances. Where a party offers an undertaking to resolve a matter, the Panel will now expect it to state expressly that the undertaking will be fulfilled as soon as practicable, a requirement previously left implied. The note also signals that the Panel may be less willing to accept an undertaking at all from a party that has been uncooperative or has caused unnecessary delay, tying the treatment of undertakings back to the conduct theme that runs through the revisions.
What we could see in the coming weeks. These are live situations drawn from public disclosures. Indicative proposals can be revised or lapse, and none is certain to become a binding deal.
Frasers Group's unconditional on-market bid at A$0.65 per share runs to 30 July, with Accent's board urging shareholders to reject it. Frasers has taken Accent's target-statement undervalue claims to the Takeovers Panel, which has not yet decided whether to conduct proceedings. The guidance is directly on point: under Guidance Note 22, a statement that an offer undervalues a company, including the undervalue implied by a recommendation to reject, must rest on clearly disclosed reasons that are soundly based and reasonable and supported by internal analysis or external advice, and directors must give shareholders some guidance as to value, even if they need not put a figure on it. Frasers' case, in essence, is that Accent's statements fall short of that standard, and it is seeking either fuller reasons or an independent expert's report. Watch for how the matter resolves and whether Frasers builds a controlling stake before the offer closes.
A US consortium of Amwins and Dragoneer has a conditional, non-binding proposal at A$6.00 cash per share, valuing the insurance-broking network at about A$7.7bn (a premium of roughly 52%), with the broking and underwriting arms to be split between the two bidders. Steadfast granted exclusivity and diligence access in June, and on 9 July the consortium re-confirmed its A$6.00 proposal, rolling exclusivity into a further four-week soft exclusivity period. On 14 July the consortium added a third member, with KKR joining as co-lead investor alongside Dragoneer in the retail broking business; the bidders said this does not change the timetable and is not a condition to signing a binding deed. Two things already favour a deal: the price held through diligence rather than being cut, and the board has signalled it intends to recommend a binding transaction on agreed terms. That early board disposition is the important tell, because across Australian private-equity approaches a supportive board is the strongest predictor of completion. The open questions now are execution rather than persuasion, chiefly the diligence and final terms, an independent expert's opinion, and whether a rival emerges. Steadfast reports its FY26 results on 26 August, a natural point for any deal news.
The outdoor-advertising group is at the centre of a private-equity contest that has escalated since late April. Pacific Equity Partners opened with an unsolicited A$1.40 per share, and I Squared Capital followed at A$1.45; the board rejected both as materially undervaluing the business but opened its books to a short due-diligence phase. The bidders returned higher: Pacific Equity Partners, I Squared Capital and Oaktree Capital Management each lodged revised proposals by scheme, while Bain Capital, an earlier bidder, has since stepped away. On 10 July all three reconfirmed, now for at least A$1.60, with the highest at A$1.65 per share (about A$845m at A$1.60), and the board intends to keep engaging with each to finalise confirmatory diligence and negotiate binding documentation, a final process it expects to take up to four weeks. The proposals remain non-binding, so watch for whether one converts to a binding, board-recommended deal, or whether a higher bid emerges.
Perpetual's board rejected an unsolicited proposal from Windflower, understood to be backed by EQT, at A$21.64 cash per share (about A$2.5bn), as failing to reflect fair value for control. The approach caps a bruising few years: its heavily criticised 2023 Pendal acquisition led to a A$547m write-down in 2024, and its 2024 agreement to sell the wealth management and corporate trust businesses to KKR for about A$2.2bn unravelled in early 2025 after an unexpected ATO tax ruling slashed the value to shareholders (the wealth arm has since been agreed for sale separately to Bain Capital). On 15 July EQT returned with a revised proposal at A$22.07 per share, up 2%, by scheme and still non-binding, conditional on that Bain Capital sale completing plus diligence, binding documents and regulatory approvals. EQT stipulated the proposal would lapse if disclosed, but Perpetual disclosed it regardless, and the board is now considering it with no certainty of a binding offer.